According to a study of more than 5.5 million adults aged 50 years or older, vaccination with the bivalent BA.1 mRNA booster ...

Updated 2024-2025 COVID-19 vaccines significantly reduced the risk for hospitalization and severe outcomes despite the emergence of new viral lineages.

Dr. (Hal) Scofield and I received lots of great questions when we visited the Kiwanis Club of Downtown Oklahoma City a few weeks ago. We used one, and here’s another interesting one: COVID ...

COVID-19 vaccinations were shown to reduce virus-related hospitalizations and severe disease-associated outcomes in immunocompetent adults. The findings from a recently published JAMA Network Open ...

The severity of SARS-CoV-2 infections has waned since 2020, and uncertainty about the value of annual COVID shots has helped drive down adult vaccination rates. Among veterans who received a 2024-2025 ...

Subscribe to our newsletter for the latest sci-tech news updates. Data in this new study shows that the 2024–2025 COVID-19 vaccines provide similar protection to the previous formulation. They were ...

Immunizations used to treat COVID-19, respiratory syncytial virus (RSV) and influenza safely reduce the risk of adverse outcomes among people of all ages, according to a systematic analysis of 511 ...

A systematic review of 511 studies showed that immunization against COVID-19, RSV, and influenza was safe and effective in people of all ages. The researchers reviewed the latest evidence since the ...

Amid the declining clinical severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and diminishing public uptake of annual coronavirus disease 2019 (Covid-19) vaccines, ...

If proven effective in humans, this vaccine could potentially eliminate the need for separate annual jabs for illnesses like ...